Abstract
The purpose of this article is to compare optical coherence tomography angiography (OCTA) and indocyanine green angiography (ICGA) in patients with central serous chorioretinopathy (CSC). OCTA, ICGA and fluorescein angiography (FA) images of all enrolled patients were collected and compared. Abnormal areas were annotated on en face choriocapillaris OCTA and ICGA images and compared with each other. We found three main types of anomalies in choriocapillaris OCTA images: type A, coarse granulated high reflective area (61 eyes [92.4%]); type B, roundish dark halo around Type A (54 eyes [81.8%]); and type C, coarse granulated low reflective area (66 eyes [100%]). There were 54 eyes (81.8%) that exhibited all three types abnormalities, 7 (10.6%) had only type A and C abnormalities, and 5 (7.6%) had only type C abnormalities. The Mean JI of type A on OCTA and hyperfluorescence area on ICGA was 0.84 ± 0.15 and 0.82 ± 0.23 for grader 1 and 2, respectively. Type A area on OCTA had a statistically larger area than hyperfluorescence on ICGA (P = 0.01 [paired t-test]). In summary, abnormalities were found on OCTA images of CSC. Coarse granulated high reflective area in OCTA corresponded well with the hyper-permeability area in ICGA in most of the eyes.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Introduction
Central serous chorioretinopathy (CSC) is a disorder characterized by serous retinal detachment with or without retinal pigment epithelial (RPE) detachment, and associated with hyper-permeability of the choriocapillary layer. A higher prevalence of CSC among men in their fourth and fifth decades of life has been observed, with the male: female ratio ranging from 2.7:1 to 7:11. CSC incidence varies among ethnic groups, and a higher frequency has been suspected among Asians, Caucasians, and Hispanics compared with African Americans1. CSC patients report symptoms including blurred vision, relative central scotoma, metamorphopsia, moderate dyschromatopsia, hypermetropization, and micropsia, and reduced contrast sensitivity2. Bilateral, multifocal cases of CSC, with worsened visual acuity, have been reported more frequently in Asians1,2,3. In most cases, acute CSC (disease duration ≤6 months) is self-limiting with favorable outcome; however, 30% to 50%4 of acute CSC may be associated with permanent vision loss or recur within one year. Chronic CSC (disease duration >6 months) is characterized by diffuse leakage on fluorescein angiography (FA), widespread RPE alterations and photoreceptor defects, resulting in progressive and inevitable vision loss5. Despite observations, CSC with paramacular leakage points can be treated with laser photocoagulation. For individuals with CSC and leakage points directly on the macula, half-dose photodynamic therapy (HD-PDT) is the mainstay treatment choice6.
In addition to a full clinical examination, FA, indocyanine green angiography (ICGA), and optical coherence tomography (OCT) can help diagnose CSC7. OCT reveals subretinal fluid (SRF), with or without serous pigment epithelial detachment (PED), and the thickening of choroid. Intraretinal fluid (IRF) and macular cysts may be encountered in some patients with chronic CSC. A double-layer sign (DLS), defined as an undulated RPE layer and intact underlying Bruch’s membrane, appears in 87% of chronic and 63% of acute CSC patients8. FA reveals one or multiple leakage points and/or diffuse RPE alterations. ICGA reveals choriocapillary hyperpermeability areas with hyperfluorescence. ICGA often reveals a more diffuse hyperfluorescent area compared with FA. In some cases, ICGA may reveal choriocapillary ischemia with hypofluorescence in the early stages9.
Although the imaging techniques mentioned above can help to diagnose most cases of CSC and differentiate from other diseases, FA and ICGA are invasive techniques that require a high demand for trained technicians and patient cooperation. Recently, OCT angiography (OCTA) has emerged as a new imaging technology. Dyeless OCTA is a fast, easy, and noninvasive technique, combining Doppler OCT and en face OCT10,11. More importantly, OCTA detects the movement of red blood cells, which facilitates blood flow imaging and provides the ability to analyze blood flow in different layers10,12. Because abnormal choroidal blood flow is considered to be important in the pathogenesis of CSC, OCTA may provide additional information about blood supply in CSC, and may help to better understand the underlying pathophysiology of the disease. Previous studies7,13,14,15,16 have described findings of OCTA with CSC. Hence, the aim of the present study was to describe OCTA findings in Asian patients with chronic and acute CSC, and to compare OCTA with traditional angiographic imaging modalities.
Methods
Patients
This study was performed at the Department of Ophthalmology, Peking University People’s Hospital, Beijing, China. All patients diagnosed with symptomatic CSC between February 2016 and January 2017 were included. The inclusion criteria were as follows: presence of active focal or diffuse leakage on FA; presence of SRF with or without serous PED on OCT; and presence of abnormal dilated choroidal vasculature on ICGA. Patients with other ocular conditions commonly associated with SRF, such as choroidal neovascularization, polypoidal choroidal vasculopathy (PCV), diabetic retinopathy, retinal vascular occlusion, Coat’s disease, or any disease that may affect the quality of imaging (quality of OCTA images <6), such as cataract, high myopia or nystagmus; history of ocular surgeries including retinal laser; pregnancy; any uncontrolled systemic disease; or any condition rendering patients intolerable to image acquisition were excluded. The research protocol adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all subjects, and the protocol was approved by Ethics Committee of People’s Hospital of Peking University.
All patients underwent a comprehensive ophthalmological examination, including best-corrected visual acuity (BCVA), intraocular pressure, slit-lamp biomicroscopy, dilated fundus examination, FA (FF 450plus, Carl Zeiss Meditec AG, Germany), ICGA (Heidelberg Engineering, Heidelberg, Germany) and OCTA (CIRRUS HD-OCT Model 5000, Carl Zeiss Meditec, Germany). The spectral domain OCT instrument uses an algorithm, known as OCT microangiography-complex, that is capable of scanning at a rate of 68,000 A-scans per second and introduces improved tracking software known as FastTracTM retinal-tracking technology17. All studied eyes were scanned using Angio scan 6 × 6 mm section, 3 × 3 mm section, and HD 21 lines. The built-in OCTA software was used to manually alter the automated segmentation if necessary. All OCTA examinations were performed by one well-trained physician (HJ) on the same day when FA and ICGA were performed to maximize the comparability of the different modalities.
Two experienced masked observers (QJF and ZMW) independently read the OCTA and ICGA images. En face choriocapillary OCTA images and representative ICGA images at early (within 30 s post-injection) and mid phase (60–180 s post-injection) were exported in JPG format and imported into ImageJ (version 1.4.3.67, 2016) for qualitative analysis. The OCTA images and ICGA images were aligned using Photoshop CS6 (version 13.0.0.0, Adobe, San Jose, CA, USA). After translation, rotation, and rescaling the target images, three user-specified landmarks on both modalities were accurately matched. A representative example of registered images is shown in Fig. 1.
Each observer annotated abnormal areas on en face choriocapillary OCTA images, hyperfluorescence area on mid-phase ICGA images, and hypofluorescence area on early-phase ICGA images. Adjacent abnormal areas that appeared confluent to each other were amalgamated into a single area.
To determine interobserver agreement of image annotations, spatial overlap of the annotations of type A on en face choriocapillary OCTA and the hyperfluorescence area on mid-phase ICGA was calculated separately according to Jaccard index (JI) as follows:
A and B represent the area of the smallest rounds that covered the annotation of grader A and grader B. JI was the ratio of intersection area of the two rounds divided by the union area of the two rounds. A representative example of how they were defined is shown in Fig. 2. The spatial correspondence of type A on en face choriocapillaris OCTA and the hyperfluorescence area on mid-phase ICGA was measured in the same manner according to JI.
A qualitative analysis and comparison of the entire imaging data set were conducted. Statistical analysis was performed using a commercially available spreadsheet program (Excel version 14.0; Microsoft Corporation, Redmond, WA, USA). The Student’s t-test for paired samples and Chi-squared test were used for statistical analysis; P < 0.05 was considered to be statistically significant.
Results
This study included 72 eyes of 64 patients (17 women and 47 men) with a mean age of 46.3 ± 10.5 years. Mean BCVA was 0.35 ± 0.29logMAR. 56 patients exhibited a unilateral involvement, whereas the disease occurred bilaterally in 8 patients. Of the 72 eyes, 44 (61.1%) were diagnosed with acute CSC and the remainder (38.9%) with chronic CSC.
We found 54 eyes (75%) presenting double-layer sign (DLS) in OCT B-scans. 6 of them (mean age of 57, 4 men and 2 women) were found abnormal vascular network, which could be choroidal neovascularization (CNV) or branching vascular network (BVN), within the DLS on OCTA images after manually adjusting the slab boundary just above and under the DLS. These 6 eyes were excluded for the following analyze of OCTA images and the comparison of OCTA and ICGA images. Patient demographics and clinical characteristics of the remained 66 eyes are listed in Table 1.
Abnormal choriocapillaris OCTA images were noticed in all 66 remained eyes. According to the abnormal patterns, three types of abnormalities were defined: type A, coarse granulated high reflective area (outlined in red in Fig. 3); type B, roundish dark halo around type A (outlined in blue in Fig. 3); and Type C, coarse granulated low reflective area (outlined in yellow in Fig. 3). Type A, B and C abnormalities were present in 61 (92.4%), 54 (81.8%), 66 (100%) eyes, respectively. There were 54 (81.8%) eyes that exhibited all three types abnormalities, 7 (10.6%) had type A and C abnormalities, and 5 (7.6%) only had type C abnormalities.
All type B abnormality collocated with SRF on structural OCT. Patients with type B abnormality exhibited a greater mean maximum SRF thickness than patients without type B abnormalities (538.0 ± 230.8 µm versus 242.8 ± 180.1 µm; P < 0.01) (Fig. 4). Type B abnormality presented in 36 eyes with acute CSC and 13 eyes with chronic CSC (54.5% vs. 19.7%, respectively; P = 0.001).
Type A abnormalities presented in 61 eyes with CSC. The mean JI, which indicate the interobserver agreement of type A on OCTA and the hyperfluorescence area on ICGA, was 0.92 ± 0.05 and 0.93 ± 0.04 respectively. The mean JI of type A on OCTA and the hyperfluorescence area on ICGA was 0.84 ± 0.15 for grader 1 and 0.82 ± 0.23 for grader 2. The area of type A abnormality on OCTA and the hyperfluorescence area on ICGA were decided after adjudication between the two graders and then compared with one another in the same patient. If the difference was within 10% of the hyperfluorescence area on ICGA, they were defined as equal. The area of type A abnormality on OCTA was equal to the hyperfluorescence area on ICGA in 49 (74.2%) eyes and larger than the hyperfluorescence area on ICGA in 12 (18.2%) eyes (Fig. 5). Type A area on OCTA had a statistically larger area than hyperfluorescence on ICGA (12.7 ± 3.8 mm2 vs 11.9 ± 4.4 mm2; P = 0.01 [paired t-test]). The mean area of type A abnormalities on OCTA was 12.8 ± 4.0 mm2 in acute CSC patients and 13.4 ± 3.7 mm2 in chronic CSC (Table 2). There is no significant difference of type A area between acute and chronic patients (P = 0.72).
Type C abnormalities were observed in all 66 eyes. Type C area corresponded with the hypofluorescent area on early-phase ICGA; however, the former was larger than the latter in all eyes with the mean area of 0.22 ± 0.14 mm2 and 0.10 ± 0.07 mm2, respectively (Fig. 6).
Discussion
Although CSC is an ancient disease, its pathogenesis remains unclear. It is assumed that high levels of corticosteroid and catecholamine, coagulation and circulating antigen-antibody complexes in vessels, and compression of pachychoroid vascular to choriocapillaris, results in dysfunction and ischemia of the choroidal capillaries, compensatory hyperpermeability and leakage of the around choroidal capillaries and, subsequently, cause dysfunction in RPE, which leads to accumulation of fluid under the neuroretina. OCTA is a newly developed ophthalmic imaging technology, which enables us to view different layers of blood flow and perfusion in the retina and choroid. OCTA may facilitate the elucidation of the pathogenesis of CSC.
Recent studies have focused on multimodal imaging assessment of CSC7,9,14,16,18,19,20,21; however, only a few have performed quantitative analysis, and different OCTA findings in CSC have been reported among investigators. Teussink13 et al. compared OCTA and ICGA in 18 eyes with chronic CSC. They found reduced flow surrounded by hyper-perfused areas on choriocapillaris OCTA. Chan et al.20 studied 12 eyes with acute CSC and 14 with chronic CSC, and found high signal intensity on choriocapillary OCTA in all eyes and believed this pattern demonstrated dilated capillaries of the choroid.
In our study, we found 3 types of abnormalities at the level of choriocapillaris on OCTA. The most common abnormality was the coarse granulated low reflective spot (Type C), which was found in all eyes. Since we have known that various factors such as PED, and subretinal fibrin might cause shadow artifacts16, We had used combinations of OCT B scan and color fundus photograph to exclude shadow artifact at choriocapillaris level caused by PED, fibrin and also the migration of pigment. The low signal area caused by shadow effect was not included in our type C area in our study. Shinojima et al. had also found low-flow signal in all their 58 studied CSC eyes. They thought it might indicate the thinned choriocapillaries being pushed upward by pachyvessles or low blood flow at the choriocapillaries level16. Our finding demonstrates the reduced choroidal blood flow in CSC and is consistent with other earlier reports. Scheider et al. found delayed choroidal filling on ICGA at the site of the hot spot in 82% of CSC patients22. Kitaya et al. had found delays in arterial filling in 75% CSC eyes on ICGA and the choroidal blood flow in CSC eyes was 45% lower than in fellow eyes23. Comparison of OCTA and ICGA images revealed that the type C abnormality area corresponded with the hypo-fluorescence area on early-phase ICGA; however, the former was larger than the latter in all eyes. This might because the hypo-fluorescence area on early-phase could be easily blocked by the leakage of choriocapillary or stain from subretinal fibrin content in later phase ICGA. And these finding suggest that OCTA might be more valuable than ICGA in revealing choriocapillary hypo-perfusion.
In our study, the type A abnormality, which was the coarse granulated high reflective area, was present in 61 (92.4%) eyes. In the study by Chan et al., however, high signal intensity on choriocapillary OCTA was observed in all eyes; the different result may be explained by the smaller sample size of their study20. Although it remains unclear what the type A represents, since there was high spatial correspondence between type A abnormality on OCTA and hyperfluorescence area on ICGA (mean JI 0.84 ± 0.15 for grader 1 and 0.82 ± 0.23 for grader 2), we presume it was caused by the dilation and increased blood flow of choriocapillaries in CSC patients. RPE atrophy may also contribute to the type A abnormality in chronic CSC eyes, but by comparing the OCTA images with the FA and OCT B scan images, type A area was much larger than the RPE atrophy area in certain eyes. Furthermore, if type A area was merely artifacts caused by the atrophy of RPE due to long lasting SRF, it should be more frequent in the chronic CSC than the acute CSC since RPE atrophy was more frequent in the chronic CSC, but in fact we found there is no significant difference of type A area between acute and chronic patients (P = 0.72). Automatic segmentation error might also cause artifacts and affect the abnormal finding at choriocapillaris level, one must be cautious in the interpretation of all types of abnormalities at the level of choriocapillaris on OCTA.
The mean type A area was larger than high permeability area on ICGA (12.7 ± 3.8 mm2 vs 11.9 ± 4.4 mm2; P = 0.01[paired t-test]) in our study. 49 eyes (74.2%) exhibited an equal area of type A abnormality on OCTA and hyperfluorescence area on ICGA, which was consistent with the findings in the study by Teussink et al.13, while 12 eyes exhibited a larger highly reflective area on OCTA than on ICGA, and 5 eyes did not present type A abnormality on OCTA at all. This finding may be explained by the different mechanism of OCTA and ICGA imaging. OCTA depicts blood flow dependent on intravascular cell movement and maybe affected by the velocity of blood flow. If the blood flow is too high or too slow, it may be beyond the test limitations of the OCTA device, and we would not be able to detect the abnormality. Although ICGA depicts blood flow independent of intravascular cell movement, as long as there is plasma, it is visible on ICGA. Different imaging modalities provide blood flow information that is supplementary to one another. Another possible explanation is that the dilation of choriocapillaries and increased blood flow within them may not present in all CSC patients, or not in all stages of CSC.
In our study, the type B abnormality exhibited a very regular round or oval shape, and presented in 36 eyes with acute CSC and 13 eyes with chronic CSC (87.8% vs. 52%; P = 0.001). It was caused by the shadow effect of SRF because we found it co-located with SRF on structural OCT in all eyes. Patients with the type B abnormality had a greater mean maximum SRF thickness than patients without type B abnormalities. We postulate the thickness and the composition of the SRF may be an influential factor in the shadow effect.
The inter-observer agreement for type A on OCTA and hyperfluorescence area on ICGA was higher than Teussink et al. reported13. That was mainly because we were using a circumcircle of the abnormal area instead of the border of the abnormal area on OCTA to calculate the JIs. The reason why we chose to use different methods was as follows. First, the border between the appearance of healthy and affected area on OCTA may not easily be drawn between graders, even though the appearance of these changes was significantly different from the fairly homogeneous appearance of the healthy choriocapillary layer. Second, we used a round laser spot that covered the choriodal lesion related to the active leakage when applying PDT to CSC patients, we believe a circumcircle would be more practical in our clinic. Our study also revealed a higher agreement of type A abnormality on OCTA and hyperfluorescence on ICGA, and this result may provide the opportunity to use OCTA to guide PDT for active CSC patients. Whether OCTA-guided PDT is equally as effective as ICGA-guided PDT still needs further prospective study to draw a definitive conclusion.
Among OCTA studies of CSC, our investigation included the most number of patients; nevertheless, it was still limited by cross-sectional data acquisition. We included treatment-naïve patients only and excluded potential confounders of different interventions on OCTA images. However, the manual segmentation and annotation methods could also be a factor that may have introduced bias in the result. Because of the limited length of each OCTA scan, we only compared the foveal-centered OCTA images with the ICGA images at the corresponding position and did not perform the OCTA image montage because it was time prohibitive. We were using spectral domain OCTA but not swept source OCTA instrument in this study and it is not satisfying for choroidal circulation at this moment because of OCT light attenuation due to RPE. Because of this limitation we only analyzed the choriocapillary layer but not the Sattler and Haller layer. Nevertheless, we believe that with development of OCTA technology, wide-field swept source OCTA images would provide more information.
In conclusion, OCTA enables noninvasive visualization of the retinal and choroidal vasculature in CSC patients. Abnormalities were found in all en face choriocapillaris OCTA images of CSC. The most common abnormality was the coarse granulated low reflective area and the coarse granulated high reflective area on en face choriocapillaris OCTA, which suggested choriocapillary ischemia and compensatory dilation were important in the pathogenesis of CSC. Coarse granulated high reflective area in OCTA corresponded well with the hyper-permeability area in ICGA and may guide PDT instead of ICGA in the future.
References
Nicholson, B., Noble, J., Forooghian, F. & Meyerle, C. Central serous chorioretinopathy: update on pathophysiology and treatment. Survey of ophthalmology 58, 103–126 (2013).
Daruich, A. et al. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Progress in retinal and eye research 48, 82–118 (2015).
Liegl, R. & Ulbig, M. W. Central serous chorioretinopathy. Ophthalmologica. Journal international d’ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 232, 65–76 (2014).
Ma, J., Meng, N., Xu, X., Zhou, F. & Qu, Y. System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy. Acta ophthalmologica 92, e594–601 (2014).
Zhao, M. et al. Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin. Retina 29, 1155–1161 (2009).
Wong, K. H. et al. Central serous chorioretinopathy: what we have learnt so far. Acta ophthalmologica 94, 321–325 (2016).
Feucht, N., Maier, M., Lohmann, C. P. & Reznicek, L. OCT Angiography Findings in Acute Central Serous Chorioretinopathy. Ophthalmic surgery, lasers & imaging retina 47, 322–327 (2016).
Yang, L. H., Jonas, J. B. & Wei, W. B. Optical Coherence Tomography–Assisted Enhanced Depth Imaging of Central Serous Chorioretinopathy. Invest Ophthalmol Vis Sci. 54, 4659–4665 (2013).
Quaranta-El Maftouhi, M., El Maftouhi, A. & Eandi, C. M. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. American journal of ophthalmology 160, 581–587 e581 (2015).
Lumbroso, B., Huang, D., Jia, Y., Fujimoto, J.G. & Rispoli, M. Clinical Guide to Angio-OCT (2015).
Gao, S. S., Liu, G., Huang, D. & Jia, Y. Optimization of the split-spectrum amplitude-decorrelation angiography algorithm on a spectral optical coherence tomography system. Opt Lett. 41, 496 (2015).
Spaide, R. F., Klancnik, J. M. J. & Cooney, M. J. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 133, 45–50 (2015).
Teussink, M. M. et al. OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy. Invest Ophthalmol Vis Sci 56, 5229–5237 (2015).
Costanzo, E. et al. Optical Coherence Tomography Angiography in Central Serous Chorioretinopathy. Journal of ophthalmology 2015, 134783 (2015).
Cakir, B. et al. Possibilities and Limitations of OCT-Angiography in Patients with Central Serous Chorioretinopathy. Klinische Monatsblatter fur Augenheilkunde 234, 1161–1168 (2017).
Shinojima, A., Kawamura, A., Mori, R., Fujita, K. & Yuzawa, M. Findings of Optical Coherence Tomographic Angiography at the Choriocapillaris Level in Central Serous Chorioretinopathy. Ophthalmologica. Journal international d’ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 236, 108–113 (2016).
Rosenfeld, P. J. et al. ZEISS Angioplex Spectral Domain Optical Coherence Tomography Angiography: Technical Aspects. Developments in ophthalmology 56, 18–29 (2016).
Bonini Filho, M. A. et al. Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography. JAMA ophthalmology 133, 899–906 (2015).
Ang, M. et al. Optical coherence tomography angiography and indocyanine green angiography for corneal vascularisation. Br J Ophthalmol 100, 1557–1563 (2016).
Chan, S. Y., Wang, Q., Wei, W. B. & Jonas, J. B. Optical Coherence Tomographic Angiography in Central Serous Chorioretinopathy. Retina 36, 2051–2058 (2016).
Wang, Y., Chen, Z. Q., Wang, W. & Fang, X. Y. Multimodal Imaging Evaluations of Focal Choroidal Excavations in Eyes with Central Serous Chorioretinopathy. Journal of ophthalmology 2016, 7073083 (2016).
Scheider, A., Hintschich, C. & Dimitriou, S. Central serous chorioretinopathy. Studies of the site of the lesion with indocyanine green. Ophthalmologe 91, 745–751 (1994).
Kitaya, N. et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 87, 709–712 (2003).
Acknowledgements
The authors thank Xiulan Xu for assistance. Supported by the National Natural Science Foundation of China (Grant 81570858). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
Jie Hu and Jinfeng Qu designed the study and wrote and revised the manuscript. They contributed equally to this paper and should be considered both the first author. Zhenyu Piao, Yuou Yao, Guosheng Sun and Mengyang Li helped collect the data. Mingwei Zhao is the supervisor of the whole subject.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hu, J., Qu, J., Piao, Z. et al. Optical Coherence Tomography Angiography Compared with Indocyanine Green Angiography in Central Serous Chorioretinopathy. Sci Rep 9, 6149 (2019). https://doi.org/10.1038/s41598-019-42623-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-42623-x
- Springer Nature Limited
This article is cited by
-
Chronic Central Serous Chorioretinopathy in Elderly Subjects: Structure and Blood Flow Characteristics of Retina and Choroid
Ophthalmology and Therapy (2024)
-
Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies
Eye and Vision (2023)
-
Optical coherence tomography angiography–guided vs indocyanine green angiography–guided half-dose photodynamic therapy for acute central serous chorioretinopathy: 6-month randomized trial results
Graefe's Archive for Clinical and Experimental Ophthalmology (2023)
-
Comparison of swept-source OCTA and indocyanine green angiography in central serous chorioretinopathy
BMC Ophthalmology (2022)
-
Early alterations in retinal microvasculature on swept-source optical coherence tomography angiography in acute central serous chorioretinopathy
Scientific Reports (2021)